JP2023540350A5 - - Google Patents
Info
- Publication number
- JP2023540350A5 JP2023540350A5 JP2023515095A JP2023515095A JP2023540350A5 JP 2023540350 A5 JP2023540350 A5 JP 2023540350A5 JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023515095 A JP2023515095 A JP 2023515095A JP 2023540350 A5 JP2023540350 A5 JP 2023540350A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound according
- c6alkyl
- substituted
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074220P | 2020-09-03 | 2020-09-03 | |
| US63/074,220 | 2020-09-03 | ||
| PCT/US2021/049003 WO2022051583A1 (en) | 2020-09-03 | 2021-09-03 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and their uses as orexin-2 receptor agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540350A JP2023540350A (ja) | 2023-09-22 |
| JP2023540350A5 true JP2023540350A5 (enExample) | 2024-10-02 |
| JP7811578B2 JP7811578B2 (ja) | 2026-02-05 |
Family
ID=78078371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515095A Active JP7811578B2 (ja) | 2020-09-03 | 2021-09-03 | 中環状または大環状ベンジル置換複素環誘導体およびオレキシン－２受容体アゴニストとしてのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230331720A1 (enExample) |
| EP (1) | EP4208465A1 (enExample) |
| JP (1) | JP7811578B2 (enExample) |
| CN (1) | CN116635393A (enExample) |
| TW (1) | TW202227433A (enExample) |
| WO (1) | WO2022051583A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI4065585T3 (fi) | 2019-11-25 | 2025-09-26 | Alkermes Inc | Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä |
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| US12006330B2 (en) | 2020-12-21 | 2024-06-11 | Alkermes, Inc. | Substituted macrocyclic compounds and related methods of treatment |
| US11760747B2 (en) | 2020-12-21 | 2023-09-19 | Alkermes, Inc. | Substituted piperidino compounds and related methods of treatment |
| WO2022251304A1 (en) * | 2021-05-26 | 2022-12-01 | Alkerme, Inc. | Substituted carbamate macrocyclic compounds and related methods of treatment |
| KR20240157067A (ko) * | 2022-03-01 | 2024-10-31 | 센테사 파마슈티칼스 (유케이) 리미티드 | 미디엄- 또는 마크로-시클릭 벤질-치환된 헤테로사이클 유도체 및 관련 용도 |
| CN119677753A (zh) * | 2022-04-22 | 2025-03-21 | 帝人制药株式会社 | 氧杂氮杂环庚三烯衍生物 |
| CN114716319B (zh) * | 2022-04-28 | 2024-03-26 | 浙江工业大学 | 一种联芳氧基烯酸酯类化合物的合成方法 |
| AR130709A1 (es) * | 2022-10-07 | 2025-01-08 | Kissei Pharmaceutical | Compuesto de ciclopentano |
| WO2024095158A1 (en) | 2022-10-31 | 2024-05-10 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
| KR20250155550A (ko) | 2023-03-16 | 2025-10-30 | 다케다 야쿠힌 고교 가부시키가이샤 | 매크로시클릭 헤테로시클 화합물 및 이의 용도 |
| US20240425521A1 (en) | 2023-06-01 | 2024-12-26 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
| TW202502342A (zh) | 2023-06-02 | 2025-01-16 | 日商武田藥品工業股份有限公司 | 食慾素２受體促效劑用於改善睡眠期間之呼吸功能的用途 |
| TW202535890A (zh) * | 2023-10-20 | 2025-09-16 | 日商帝人製藥股份有限公司 | 氧氮呯衍生物之結晶或其溶劑合物之結晶 |
| WO2025124698A1 (en) | 2023-12-12 | 2025-06-19 | Idorsia Pharmaceuticals Ltd | Aryl sulfone and sulfanone derivatives as orexin receptor modulators |
| TW202542165A (zh) | 2023-12-19 | 2025-11-01 | 瑞士商愛杜西亞製藥有限公司 | 大環食慾素激動劑 |
| WO2025229493A1 (en) | 2024-04-29 | 2025-11-06 | Takeda Pharmaceutical Company Limited | Dosing of orexin type 2 receptor agonists |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| PE20081229A1 (es) * | 2006-12-01 | 2008-08-28 | Merck & Co Inc | Antagonistas de receptor de orexina de diazepam sustituido |
| US20200207734A1 (en) | 2017-08-03 | 2020-07-02 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| SG11202106791XA (en) * | 2019-01-31 | 2021-07-29 | Takeda Pharmaceuticals Co | Heterocyclic compound and use thereof |
| FI4065585T3 (fi) * | 2019-11-25 | 2025-09-26 | Alkermes Inc | Substituoituja makrosyklisiä yhdisteitä ja niihin liittyviä hoitomenetelmiä |
-
2021
- 2021-09-03 WO PCT/US2021/049003 patent/WO2022051583A1/en not_active Ceased
- 2021-09-03 CN CN202180074185.9A patent/CN116635393A/zh active Pending
- 2021-09-03 US US18/024,236 patent/US20230331720A1/en active Pending
- 2021-09-03 JP JP2023515095A patent/JP7811578B2/ja active Active
- 2021-09-03 TW TW110132882A patent/TW202227433A/zh unknown
- 2021-09-03 EP EP21786656.5A patent/EP4208465A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023540350A5 (enExample) | ||
| JP7431900B2 (ja) | （ｓ）－３－（４－（（４－（モルホリノメチル）ベンジル）オキシ）－１－オキソイソインドリン－２－イル）ピペリジン－２，６－ジオンの塩及び固体形態、並びにそれらを含有する組成物及び使用方法 | |
| KR101593242B1 (ko) | ６-, ７- 또는 ８-치환된 퀴나졸리논 유도체, 및 그를 포함하는 조성물 및 그의 사용 방법 | |
| JP6359563B2 (ja) | ３−（５置換−４−オキソキナゾリン−３（４ｈ）−イル）−３−ジュウテロピペリジン−２，６−ジオン誘導体 | |
| JP2023527575A5 (enExample) | ||
| JP5959543B2 (ja) | ３−（５−アミノ−２−メチル−４−オキソ−４ｈ−キナゾリン−３−イル）−ピペリジン−２，６−ジオンの固体形態、並びにそれらの医薬組成物及び使用 | |
| JP2018502891A5 (enExample) | ||
| CN103382197A (zh) | N-甲基氨甲基异吲哚化合物和包含它的组合物及其使用方法 | |
| JP2011509309A5 (enExample) | ||
| JP2025507852A5 (enExample) | ||
| JP2007508361A5 (enExample) | ||
| AU2017254523A1 (en) | Compounds and compositions for treating conditions associated with NLRP activity | |
| JP2019529490A5 (enExample) | ||
| RU2011137419A (ru) | Обратные агонисты и антагонисты гистамина н3 и способы их применения | |
| JP2014528485A5 (enExample) | ||
| JP2014526469A5 (enExample) | ||
| JPH05320142A (ja) | 中枢神経系に薬理活性をもつ化合物 | |
| JP2009526831A5 (enExample) | ||
| EP3893945A1 (en) | Cromolyn esters and uses thereof | |
| TW201215605A (en) | Manufacturing process for pyrimidine derivatives | |
| US20140057975A1 (en) | Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes | |
| JP2019532069A5 (enExample) | ||
| JP2018534300A5 (enExample) | ||
| CN105658634B (zh) | 作为TCR-Nck相互作用的抑制剂的被醇盐取代的色烯衍生物 | |
| RU2019111188A (ru) | Кетоновые ингибиторы лизин-специфичного гингипаина |